---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-005068"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2024-01-17T23:59:59+00:00"
generated_at: "2026-06-06T22:53:41.847818+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Orthofix appoints Julie Andrews as CFO with inducement stock awards and severance agreement

## Summary
- Julie Andrews started as CFO on Jan 15, 2024; previously CFO at Smart Wires and SVP Finance at Wright Medical.
- Received inducement grants: performance-based RSUs for 65,934 shares (at target), time-based RSUs for 32,967 shares, and options for 76,878 shares.
- Severance equal to 1.0x base salary + target bonus (1.5x on change in control) plus COBRA reimbursement for up to 12 months.
- Options vest when service conditions met and stock price averages 150% of grant date price over one month.
- Interim CFO Geoffrey Gillespie thanked; company expects Andrews to help drive growth and shareholder value.

## SEC filing metadata
- accession: 0000950170-24-005068
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2024-01-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/0000950170-24-005068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/ofix-20240115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-005068
- JSON: https://secwatch.observer/filing/0000950170-24-005068.json
- Plain text: https://secwatch.observer/filing/0000950170-24-005068.txt

## Key facts
- Executive change
  Julie Andrews was appointed as Chief Financial Officer at Orthofix Medical Inc..
  - Action: began service
  - Role: Chief Financial Officer
  source text: On January 15, 2024, Julie Andrews began service as Chief Financial Officer of Orthofix Medical Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/0000950170-24-005068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.